Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P20366 (
substance P
)
21,176
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The two mammalian neuropeptides
substance P
(SP) and
neurokinin A
(
NKA
) have been demonstrated to stimulate
DNA
synthesis in connective tissue cells, suggesting that peripheral neurons may play a role in development and tissue regeneration. In this study we have tried to identify intracellular messengers required for SP- and
NKA
-induced
DNA
synthesis. SP and
NKA
, as well as platelet-derived growth factor (PDGF) stimulated formation of inositol phosphates in smooth muscle cells (SMC), whereas no effect on inositol phosphates formation occurred in response to nonmitogenic neuropeptides. Pretreatment of the cells with pertussis toxin markedly decreased
DNA
synthesis induced by
NKA
. This toxin inhibits formation of inositol phosphates by acting on a regulatory G-protein. Calcium and calmodulin antagonists also inhibited
NKA
-induced
DNA
synthesis. These results imply that the mitogenic signal(s) produced by activated neuropeptide receptors involves formation of inositol phosphate and activation of a calcium/calmodulin dependent process. We further report that other neuropeptides occurring in peripheral neurons, i.e., vasoactive intestinal polypeptide, calcitonin gene-related peptide, neuropeptide Y, somatostatin, or cholecystokinin, are without growth-stimulatory effect on cultured SMC.
...
PMID:Coupling between inositol phosphate formation and DNA synthesis in smooth muscle cells stimulated with neurokinin A. 245 38
The effects of upper incisor separation on the submandibular and sublingual glands of rats were examined biochemically, immunohistologically, and radio-immunologically during 28 days of treatment. Lateral separation of the upper incisors by application of force from an orthodontic appliance caused significant enlargement of the sublingual and submandibular glands of rats by three and seven days, respectively, after the beginning of the orthodontic treatment. This enlargement was followed by a significant increase of both RNA and
DNA
content, with some evidence of hyperplasia and hypertrophy. The enlargement was also associated with a significant increase of
substance P
at early stages after treatment, suggesting the involvement of the sensory nerves. These changes were largely inhibited by phenoxybenzamine, an alpha-adrenergic blocker, but not by atropine or morphine. Wet weights and RNA contents of the sublingual glands were markedly reduced by atropine. In comparison with control animals, the enlarged submandibular glands of rats subjected to orthodontic treatment secreted additional proteins identical with those secreted by glands enlarged by chronic administration of isoproterenol. In addition, chemical sympathectomy with 6-hydroxydopamine and phenoxybenzamine stimulated the synthesis of these abnormal proteins, but atropine and morphine did not. In contrast, protease activities in the convoluted granular tubule cells in the submandibular glands were increasingly reduced after treatment, as seen in rats subjected to chronic treatment with isoproterenol. However, the submandibular and sublingual glands completely recovered after removal of the orthodontic appliance.
...
PMID:The effects of upper incisor separation on the submandibular and sublingual glands of rats. 245 69
The neuropeptides
substance P
(SP), somatostatin (SOM), and vasoactive intestinal peptide (VIP) have been shown to modulate lymphocyte
DNA
, RNA, and immunoglobulin synthesis. We have previously shown that SP enhances while SOM and VIP inhibit proliferation of murine splenic and Peyer's patch lymphocytes when cells were cultured with concanavalin A and neuropeptides for 72 h. Here we show that the effect of neuropeptides, in particular SP, is dependent on the amount of time that lymphocytes are incubated with NP. We found that SOM and VIP always inhibited cell proliferation for incubation times of 2 to 72 h. In contrast when cells were exposed to SP for 24 h or less, there was inhibition of [3H]thymidine uptake by both Peyer's patches and splenic lymphocytes. Significant enhancement in
DNA
synthesis by lymphocytes from both organs was only seen when cells were incubated with SP for the whole 72 h. We believe that our data may explain some of the conflicting reports regarding the effects of neuropeptides on cell proliferation.
...
PMID:The differential effect with time of neuropeptides on the proliferative responses of murine Peyer's patch and splenic lymphocytes. 246 78
We have deleted cDNA sequences encoding portions of the amino- and carboxy-terminal end of a human type I epidermal keratin K14, and examined the molecular consequences of forcing the expression of these mutants in simple epithelial and squamous cell carcinoma lines. To follow the expression of our mutant products in transfected cells, we have tagged the 3' end of the K14 coding sequence with a sequence encoding an antigenic domain of the neuropeptide
substance P
. Using
DNA
transfection and immunohistochemistry (with an antibody against
substance P
), we have defined the limits of K14 sequence necessary to incorporate into a keratin filament network in vivo without disrupting its architecture. We have also uncovered major differences in the behavior of carboxy- and amino-terminal alpha-helical mutants which do perturb the cytoskeletal network of IFs: whereas carboxy terminal mutants give rise to aggregates of keratin in the cytoplasm, amino-terminal mutants tend to produce aggregates of keratins which seem to localize at the nuclear surface. An examination of the phenotypes generated by the carboxy and amino-terminal mutants and the behavior of cells at late times after transfection suggests a model whereby initiation of filament assembly occurs at discrete sites on the nuclear envelope and filaments grow from the nucleus toward the cytoplasm.
...
PMID:Expression of mutant keratin cDNAs in epithelial cells reveals possible mechanisms for initiation and assembly of intermediate filaments. 246 49
The localization of gamma-
preprotachykinin
A mRNAs in the rat trigeminal ganglion was demonstrated by in situ hybridization histochemistry using the 32P and 35S labelled gamma-
preprotachykinin
A complementary
DNA
. In situ hybridization using 32P allowed shorter exposure times, whereas higher resolution of the hybridization signal on both film and emulsion autoradiograms was obtained using 35S. Preprotachykinin A mRNA detected by the gamma-
preprotachykinin
A probe was localized in about 15 per cent of the trigeminal ganglion cells, most of which were small or medium sized. Immunohistochemical studies using anti-
substance P
antibodies demonstrated that 15-20 per cent of total trigeminal ganglion cells were positive. These cells were small or medium sized. The result of immunohistochemistry coincided well with that of in situ hybridization histochemistry. The present study showed that the cellular localization of
preprotachykinin
A mRNA could be analysed by in situ hybridization histochemistry.
...
PMID:Demonstration of rat preprotachykinin A mRNA in the rat trigeminal ganglion by in situ hybridization histochemistry. 247 33
While screening neuropeptides for activity as growth factors we have found that bradykinin is a mitogen for Swiss 3T3 cells. It acts synergistically with insulin, and maximal effect is obtained at 10 nM. It acts through a distinct receptor, characterized as a B2 subtype using bradykinin analogues. The neuropeptides bombesin and vasopressin are also potent mitogens for Swiss 3T3 cells. The
substance P
antagonists [DArg1, DPro2, DTrp7,9, Leu11]
substance P
and [DArg1, DPhe5, DTrp7,9, Leu11]
substance P
are inhibitors of
DNA
synthesis stimulated by both bombesin and vasopressin. In the present study they were found also to inhibit bradykinin-induced mitogenesis. In contrast, the ligand-specific antagonists [Leu13-psi(CH2NH)Leu14]bombesin, [Pmp1, OMeTyr2, Arg8]vasopressin and [DArg0, Hyp3, Thi5,8, DPhe7]bradykinin showed no cross-inhibition with each others receptors. We propose therefore that the receptors for the mitogenic neuropeptides bombesin, vasopressin, and bradykinin can interact with two classes of antagonist, one recognizing the ligand binding site (e.g., [Leu13-psi(CH2NH)Leu14]bombesin) and the other recognizing a common domain shared by the three receptors (e.g., [DArg1, DPhe5, DTrp7,9, Leu11]
substance P
).
...
PMID:Two classes of antagonist interact with receptors for the mitogenic neuropeptides bombesin, bradykinin, and vasopressin. 248 37
It has been suggested that the coding for a ligand and its receptor may have originated in inverse complementary strands of the same
DNA
. This would imply a deficiency of stop codons in the complementary strand of the ligand message sequence. We have sought evidence of such deficiencies by an analysis of the usage of selected codons in 23 human neuropeptide and hormone mRNA sequences. We have also searched directly for similarities between
substance K
or
substance P
and the substance K receptor. Although bovine proopiomelanocortin has an open reading frame for the full extent of the inverse complement of the coding region, this seems to be a unique case. The data as a whole do not support the hypothesis.
...
PMID:Is there a relationship between DNA sequences encoding peptide ligands and their receptors? 253 58
The present study investigates the inhibitory effect of the novel potent benzodiazepine-related CCK-antagonist L-364,718 on pancreatic growth in the rat induced by chronic administration of caerulein and bombesin-like peptides. Caerulein, injected s.c. twice daily at a dose of 1 microgram/kg body weight, and bombesin (10 micrograms/kg) induced a similar increase (1.5-3-fold) in pancreatic wet weight, total protein, amylase, trypsin, putrescine and spermidine content after 14 days of treatment. Growth induced by caerulein showed a significant increase in total
DNA
content suggesting cellular hyperplasia, whereas bombesin-like peptides led to cellular hypertrophy. In comparison to bombesin the decapeptide neuromedin C (10 micrograms/kg) was found to be 30-50% less potent. In the same dose range, neuromedin B and the tachykinins
neurokinin A
and B, all structurally related to bombesin, had no significant trophic effect on the rat pancreas. Administration of the CCK-antagonist L-364,718 twice daily at a dose of 0.1 mg/kg or at 1.0 mg/kg, either s.c. or orally, led dose-dependently to a near-complete inhibition of the caerulein-induced trophic effect. In contrast, L-364,718 administered at identical dosages, did not affect pancreatic hypertrophy induced by bombesin and neuromedin C. It is concluded that both peptides mediate their effect on the rat pancreas directly and not via release of endogenous cholecystokinin. Tachykinins are not involved in the regulation of pancreatic growth. Caerulein- and bombesin-like peptides have comparable effects on the stimulation of protein and polyamine synthesis.
...
PMID:CCK-antagonist L-364,718: influence on rat pancreatic growth induced by caerulein and bombesin-like peptides. 254 30
Connective tissue cells proliferate actively when cultured in the presence of serum. Platelet-derived growth factor (PDGF), a basic protein of relative molecular mass approximately 30,000, has been identified as the major serum mitogen for these cells; its main physiological/pathophysiological role may be to initiate wound healing in connection with tissue injury. However, growth of cultured cells is also influenced by several other factors, including epidermal growth factor, fibroblast growth factor, insulin and somatomedins. Furthermore, Rozengurt and Sinnett-Smith recently showed that bombesin, a neuroendocrine peptide isolated from frog skin, stimulates
DNA
synthesis and cell division in cultures of a specific subtype of 3T3 cells.
Substance P
and
substance K
(also known as
neurokinin A
or
neuromedin L
) are mammalian peptides belonging to the
tachykinin
family.
Substance P
has been studied extensively; it is distributed widely throughout the central and peripheral nervous system, including primary sensory neurones, and can be released in the periphery from axon collaterals of stimulated pain fibres and contribute to the inflammatory response.
Substance K
is a member of the
tachykinin
family isolated from mammalian spinal cord; Nawa et al. determined the primary structure of two types of
substance P
precursors, one of which contained a sequence homologous to
substance K
, as well as the sequence of
substance P
. We report here that
substance P
and
substance K
stimulate
DNA
synthesis in cultured arterial smooth muscle cells and human skin fibroblasts, and that this stimulation is inhibited by the
substance P
-antagonist spantide.
...
PMID:Stimulation of connective tissue cell growth by substance P and substance K. 258 Nov 42
Systemic administration of Neurotensin, a tridecapeptide, in immature rats treated with estradiol benzoate significantly enhances uterine
DNA
synthesis as reflected by the incorporation of 3H-thymidine. The peptide may have a direct action on the uterus.
Substance P
, a related peptide, had no effect on uterine
DNA
synthesis.
...
PMID:Neurotensin enhances estradiol induced DNA synthesis in immature rat uterus. 258 23
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>